BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24069182)

  • 1. Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation in mesenchymal stem cells in a glycoprotein-130 dependent manner.
    Fernandes TJ; Hodge JM; Singh PP; Eeles DG; Collier FM; Holten I; Ebeling PR; Nicholson GC; Quinn JM
    PLoS One; 2013; 8(9):e73266. PubMed ID: 24069182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production.
    Takami M; Woo JT; Nagai K
    Cell Tissue Res; 1999 Nov; 298(2):327-34. PubMed ID: 10571121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Osteogenic-Conditioned Medium from Human Periosteum-Derived Cells on Osteoclast Differentiation.
    Park HC; Son YB; Lee SL; Rho GJ; Kang YH; Park BW; Byun SH; Hwang SC; Cho IA; Cho YC; Sung IY; Woo DK; Byun JH
    Int J Med Sci; 2017; 14(13):1389-1401. PubMed ID: 29200953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-derived oncostatin M/bone morphogenetic protein 6 in response to Mg-based materials influences pro-osteogenic activity of human umbilical cord perivascular cells.
    Wang Q; Xu L; Willumeit-Römer R; Luthringer-Feyerabend BJC
    Acta Biomater; 2021 Oct; 133():268-279. PubMed ID: 33321219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
    Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
    J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF.
    Atanga E; Dolder S; Dauwalder T; Wetterwald A; Hofstetter W
    Bone; 2011 Nov; 49(5):1090-100. PubMed ID: 21884837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation.
    Nicolaidou V; Wong MM; Redpath AN; Ersek A; Baban DF; Williams LM; Cope AP; Horwood NJ
    PLoS One; 2012; 7(7):e39871. PubMed ID: 22802946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors.
    Yamazaki H; Kunisada T; Yamane T; Hayashi SI
    Exp Hematol; 2001 Jan; 29(1):68-76. PubMed ID: 11164107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts.
    Tanaka H; Tanabe N; Shoji M; Suzuki N; Katono T; Sato S; Motohashi M; Maeno M
    Life Sci; 2006 Mar; 78(15):1733-40. PubMed ID: 16266722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
    Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA
    Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
    Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH
    Front Immunol; 2019; 10():1164. PubMed ID: 31191537
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling.
    Guihard P; Danger Y; Brounais B; David E; Brion R; Delecrin J; Richards CD; Chevalier S; Rédini F; Heymann D; Gascan H; Blanchard F
    Stem Cells; 2012 Apr; 30(4):762-72. PubMed ID: 22267310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor-dependent CD11c-positive cells differentiate into active osteoclasts.
    Ruef N; Dolder S; Aeberli D; Seitz M; Balani D; Hofstetter W
    Bone; 2017 Apr; 97():267-277. PubMed ID: 28161590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The generation of highly enriched osteoclast-lineage cell populations.
    Quinn JM; Whitty GA; Byrne RJ; Gillespie MT; Hamilton JA
    Bone; 2002 Jan; 30(1):164-70. PubMed ID: 11792580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
    Taguchi Y; Yamamoto M; Yamate T; Lin SC; Mocharla H; DeTogni P; Nakayama N; Boyce BF; Abe E; Manolagas SC
    Proc Assoc Am Physicians; 1998; 110(6):559-74. PubMed ID: 9824538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.